Discovery of a small-molecule NDR1 agonist for prostate cancer therapy
Cited by 2
Related Papers
TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer
|Oncotarget|2015|35
TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC
|Cell Death and Disease|2022|32
Alisol B 23-Acetate Inhibits IgE/Ag-Mediated Mast Cell Activation and Allergic Reaction
|International Journal of Molecular Sciences|2018|22